“Cannarma Returning to Human Knowledge that has been ignored by science for centuries”Rohit Chauhan & Keshav Agarwal – Co Founders of Cannarma

According to Rohit Chauhan, who is a Cannabis Phytocannabinoid Extraction & Analysis Researcher, Co-Founder at Cannarma, Co-Founder at Incare Lab and Life Time Scientific Member of The Italian Society of Medicinal Cannabis, and researching the hemp sector in India, It is a human right to use plant-based medicine and everyone in the world should have easy access to cannabis-based medicine.

According to Keshav Agarwal, who is a Cannabis Enthusiast, professional Tea Taster, Co-Founder at Cannarma, Co-Founder at Incare Lab, goal is to make Medicinal cannabis-based products common-place in all homes in India by 2025 as they will have a place in the house just like Sugar & Salt.

Rohit Chauhan

5 years ago while doing my Master’s studies in Biodiversity & Environmental Health with a specialization in Cannabis Plant Science from the University of Siena, Italy and I traveled across Europe to explore and learn technology across the cannabis industry. My journey on cannabis products started in the City of Cannabis – Amsterdam, The Netherlands where I worked during my university summer vacation in a Souvenir shop, where all around me only cannabis products, which pushed me to why every product over here was made with only cannabis?

This took me on my journey. A journey that raised questions about everything I learn in school and university, and which led me to start looking at the Medicinal side of Cannabis that could have health benefits without side effects. In my research in Europe, I found as the world moves into a new phase of medicines, returning to human knowledge that has been ignored by science for centuries, the horizon of treatment using cannabis phytocannabinoids is growing wider and wider. I found the Cannabis plant to be very effective from looking into Ayurvedic medicine.

Rohit Chauhan (Co-Founder) Analyzing Plant Compounds through HPLC in the Laboratory of the University of Siena, Italy

Phyto-medicine development can takes years, but patients are suffering today. The first thought must always be of the patient, and there are solutions that are proven to significantly impact their wellness.

I decided to help change the world’s perspective on cannabis medicines available in all of India and innovate the pharmaceutical Industry. After having a vast knowledge of cannabis plant science, cannabis formulations, cannabis phytocannabinoids extraction, and cannabis extraction types of equipment technology gathered in Europe, and after finishing my higher studies at the University of Siena, Italy and I decided to return to my home country India in February 2020 and launch own Medicinal Cannabis based Pharmaceutical company along with my friend Keshav Agarwal who is also Co-founder in Cannarma to develop phytomedicines with indigenous landraces of cannabis grown in North Western & Eastern Himalayas Region of India.

Keshav Agarwal
Belonging to a business background, Keshav has always valued business ethics and ensures that the customer gets the best value and quality service for the time & money they put in. Our legacy dates back to 1962 when the Dora group was established. The company is renowned for producing premium quality knitted innerwear.

Keshav started the journey back in 2011 with a dream to be able to help people live better physically and mentally through holistic ways of living!
After talking to various Cannabis Researchers, Professors and PHD Students around the globe, learning and understanding this plant for year’s, I got the certain understanding on how the Endocannabinoid systems in the body reacts with the cannabinoids by activating the Cb1 and Cb2 receptors which are responsible for a better sleep, Pain management and balanced life.

Together Rohit Chauhan and Keshav Agarwal scaled from Idea to Industry, We started as an idea; an idea to bring effective phytocannabinoid medicines to the mainstream. In the last few years, we have been able to formulate highly therapeutic values of products from Lab Research to Pilot Factory, and now to Industrial Scale Production. Our state-of-the-art infrastructure came to life in 2021 with a promise of scalable production of our hybrid phytomedicine at unprecedented Quality.


This is when Cannarma first started. The name was taken from Cannabis + Pharma, which was a hugely unexplored area in Plant science and medicine and that directly linked to cannabis pharmaceuticals. Our main aim with Cannarma is to make Phyto-cannabinoid medicines available to patients who needed them in India & Globally. Everything we made was developed from scratch: investing and slowly using funding from the patients who were happy to pay for the products. We could produce more help to more patients and spread the word of new generation phytomedicines to the world suffering from Opioid crisis, sleeping disorders, Anxiety, Depression, Arthritis pain, Chronic Pain, Neuropathic Pain, Epilepsy, Parkinson & Cancer.

Our products are 100% MADE IN INDIA. We have combined Ancient Ayurvedic Practices with cutting-edge Research & Technology. We use only Natural grown Cannabis landraces in the North Western & Eastern Himalayas Region of India. Cannarma uses Therapeutic & Medicinal grade formulation developed and approved by a scientific board of Researchers, Ayurveda experts, Doctors, Pharmacists & Biologists.

Cannarma Ultra Premium Pain Relief Massage Oil

Cannarma is an Indian-based Research & Development company licensed by the Department of Ayush to manufacture for sale of Ayurvedic products. The company makes high-quality products with all-natural principles.

Our products are laboratory tested to ensure the end-users have access to a standardized, safe, and consistent product. Our process starts with raw material procurement to the production of the final product. We take care of all the steps of production with accuracy and dedication.

Cannarma is focused on the production of cannabis-based medicines /cosmetic / nutraceutical & supplement products supported by ongoing Research & Development activities, as well as the production of Active Pharmaceutical Ingredients (API) of various cannabinoids, emerging from a self-contained supply chain that runs from procurement of raw material through extraction. We develop ULTRA PREMIUM products made by different types of phytocannabinoid through innovation and excellence, with service to match.


Cannarma is positioned as a global leader in phytocannabinoid-based medicines within the Ayurvedic Industry.

Cannarma goal is to facilitate the transformation of phytocannabinoids into true medicinal products and to provide breakthrough solutions for prevalent global health issues to improve the quality of patients’ lives. Active Research & Technology and finding new ways to access patients are at the core of Cannarma values and forward momentum. By compounding more than one standardized Natural Active Ingredient, we are creating a controlled “Entourage Effect”, meeting regulatory requirements for standardized medicine while providing the therapeutic benefits of combining several natural compounds – creating greater harmony within the body and generating better patient outcomes.

By bringing together the most experienced and curious minds from around the world with the goal of targeting and providing formulations for the most pressing medical issues which can be addressed with phytocannabinoid today, Cannarma is ensuring patients reap the benefits of a full suite of phytocannabinoid treatments into the future.

The core of Cannarma raw material procurement to extraction strategy is focused on medical research and development of the company’s medicinal cannabis products supply chain, which provides raw materials and appropriately matched genetics to treat patients with a variety of diseases across the globe.


While Cannarma is developing indication-specific formulations, we have available a range of products to allow medical professionals to prescribe as they see suited for their patients. These products range from pure, Full Spectrum Cannabis Extract Oil, extract infused products, Hemp Seed Oil, & Hemp seed oil infused products through phytocannabinoid as well as terpenes & flavonoids  formulation.

Cannarma One Step Extraction for the purest high grade therapeutic cannabis

Based on our research, our scientific board experience, and the company’s understanding of global legalization, CANNARMA has isolated formulations that have significant potential to treat the widest swath of indications.

CANNARMA has implemented these products in our portfolio as immediate and accessible solutions to patients, as patient access is the main pillar of the company’s activity globally. This agenda is supported by CANNARMA extensive experience in rollouts of medicinal cannabis programs throughout the world.

These fully GMP-compliant physiotherapeutic products are the result of the past 20 years of mixed global legalization and medical regimes, and the accompanying accrued data, and research. This provides a context for formulations with a proven significant positive impact on patients with Epilepsy, Cancer, Diabetes, Sleeping disorder, Anxiety, Depression, Arthritis & Chronic Pain, and Parkinson’s.


Cannarma has built a unique block chain system from raw material procurement to a product production supply chain that encompasses everything from raw material procurement & manufacturing, through clinical research, until the medication reaches the patients via a doctor and pharmacy.

Our ultimate goal has been to create products that are fully compliant with existing pharmaceutical regulations in every jurisdiction, with the only distinction being the presence of phytocannabinoids  from the cannabis plant.

From a doctor and patient’s point of view, they are considering a product that has been proven to be either as effective, or more effective, than their current medication, and the question of “what is it made of” is no more applicable than it is to antibiotic, anticoagulant or anti-inflammatory.

From a formulation point of view, these products are created at the highest level of pharmaceutical formulation, fully GMP supervised and compliant, and are already being provided to patients as part of clinical studies, observational studies, or special access schemes in specific countries that allow them.

Our intention is to place our products on the shelves alongside every available medication and to shift the conversation from cannabis to personalized medicine for the individual. Our desire is for patients to be given the ability to have fuller, healthier, and happier lives. Cannabis holds within its elements that can facilitate this goal, and as such we are investing ourselves in researching developing, and creating products that will have that effect, globally.

Cannarma is focused on existing in the pharmaceutical space by operating at the highest standards, providing the deepest levels of evidence and testing available, and educating and changing minds with results generated by the most important part of our company and patients.

As more research is done on this wonderful medical therapeutic ingredient its popularity is at an all-time high. Have you tried it yet?

To know more about medicinal cannabis products visit ON www.cannarma.com

India’s Ultra Premium Medicinal Cannabis-based products







About Digital Scoop India Team

Check Also

"Trailblazing Leadership: Jhalak Jain and the Rise of JK Marketing India"

“Trailblazing Leadership: Jhalak Jain and the Rise of JK Marketing India”

In the fast-paced world of digital marketing, staying ahead of the curve requires innovation, vision, and a deep understanding of consumer behavior. Jhalak Jain, the dynamic founder and CEO of JK Marketing India, has proven herself to be a trailblazer in this regard, setting new standards of excellence with her pioneering strategies and relentless pursuit of client success.

Leave a Reply

Your email address will not be published. Required fields are marked *